ASBP - Aspire Biopharma Holdings, Inc.
1.31
-0.010 -0.763%
Share volume: 116,555
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.30%
PREVIOUS CLOSE
CHG
CHG%
$1.32
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2025 | 11-14-2025 | |
| Cash flow financing | 3.094 M | 2.846 M | |
| Other financing cash flows | 0.000 | 0.000 | |
| Cash flow | 1.343 M | 0.000 | |
| Net income | -15.941 M | -1.850 M | |
| Depreciation | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | |
| Cash Change | 1.343 M | 1.742 M |